PLoS One:青少年痤疮与前列腺癌风险相关么?

2018-11-21 AlexYang MedSci原创

之前关于痤疮和前列腺癌风险关系的研究报道了并不一致的结果。最近,有研究人员进行了观察性研究的元分析来概括两者相关性的证据。研究人员在PubMed、Scopus、Web of Science和中国知网(CNKI)数据库中对文献进行了综合的搜索,截止时间到2018年,并利用随机影响模型评估了风险比(ORs)和95%置信区间(CIs),还利用了Q统计和I2指数评估了不同研究的异质性。他们的元分析总共包括

之前关于痤疮和前列腺癌风险关系的研究报道了并不一致的结果。最近,有研究人员进行了观察性研究的元分析来概括两者相关性的证据。

研究人员在PubMed、Scopus、Web of Science和中国知网(CNKI)数据库中对文献进行了综合的搜索,截止时间到2018年,并利用随机影响模型评估了风险比(ORs)和95%置信区间(CIs),还利用了Q统计和I2指数评估了不同研究的异质性。他们的元分析总共包括8个文献中报道的研究。在总的分析中,研究人员并没有发现痤疮与前列腺癌风险的相关性(OR = 1.08, 95% CI 0.93-1.25)。研究人员观察到了不同研究之间显著的异质性(P = 0.006, I2 = 64.5%)。在研究设计的亚群分析中,研究人员在研究群体中发现了显著的相关性(OR = 1.51, 95% CI 1.19-1.93),而在案例-对照研究中并没有上述相关性存在(OR = 0.98, 95% CI 0.86-1.12)。

最后,研究人员指出,他们的元分析并没有发现青少年痤疮和前列腺癌风险之间的相关性。然而,由于总分析中异质性的存在,研究群体中存在相关性。因此,良好设计的大的前瞻性研究是需要的,从而来确认上述结果。


原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2022572, encodeId=42f620225e24b, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Fri Mar 01 14:56:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061805, encodeId=ab29206180516, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Sep 12 11:56:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790296, encodeId=4e251e9029696, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Fri Mar 08 00:56:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353256, encodeId=cd0735325624, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Wed Nov 21 13:40:37 CST 2018, time=2018-11-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2022572, encodeId=42f620225e24b, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Fri Mar 01 14:56:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061805, encodeId=ab29206180516, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Sep 12 11:56:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790296, encodeId=4e251e9029696, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Fri Mar 08 00:56:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353256, encodeId=cd0735325624, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Wed Nov 21 13:40:37 CST 2018, time=2018-11-21, status=1, ipAttribution=)]
    2019-09-12 sjq027
  3. [GetPortalCommentsPageByObjectIdResponse(id=2022572, encodeId=42f620225e24b, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Fri Mar 01 14:56:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061805, encodeId=ab29206180516, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Sep 12 11:56:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790296, encodeId=4e251e9029696, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Fri Mar 08 00:56:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353256, encodeId=cd0735325624, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Wed Nov 21 13:40:37 CST 2018, time=2018-11-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2022572, encodeId=42f620225e24b, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Fri Mar 01 14:56:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061805, encodeId=ab29206180516, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Sep 12 11:56:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790296, encodeId=4e251e9029696, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Fri Mar 08 00:56:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=353256, encodeId=cd0735325624, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Wed Nov 21 13:40:37 CST 2018, time=2018-11-21, status=1, ipAttribution=)]
    2018-11-21 一个字-牛

    学习了谢谢分享

    0

相关资讯

挤爆一颗“痘”,就此生死攸关……

江苏某医院接诊了一名急诊病人,半边脸肿胀化脓,高烧40度,CT查看发现两肺多发脓肿,确诊为脓毒症,有生命危险。问询病史,这一切竟是脸上的一颗痘导致的。

痤疮(粉刺)中医治疗专家共识

痤疮是临床常见病,病程慢性,部分患者可遗留瘢痕,对其身心健康造成较大影响,中医药治疗对控制病情、减少复发和改善伴随全身症状、提高生活质量有确切疗效,本共识旨在为临床医生治疗痤疮提供指导性意见。痤疮是一种常见的毛囊皮脂腺的慢性炎症性皮肤病,属中医肺风粉刺范畴。初发者多由肺经风热、湿热内蕴,肺胃热邪上熏头面而致,久者痰瘀互结而出现结节、囊肿甚至瘢痕。近年来,由于生活节奏加快,压力增大,肝郁在本病的发病

战痘法则,避孕药与痤疮,你不得不知!

欧盟监管机构表示,考虑到避孕药药物对于静脉血栓栓塞(VTE)有可预见风险,含有地诺孕素 2 mg和炔雌醇0.03 mg的口服避孕药仍然可用于治疗女性中度痤疮,但只有在其它治疗失败后才能使用。

J Invest Dermatol:打一针治痘痘!科学家使用免疫疗法开发痤疮疫苗,有望战痘成功

美国加州大学圣迭戈分校的Huang Chunming博士发现抑制痤疮丙酸杆菌的外毒素CAMP可以很大程度上减缓痤疮丙酸杆菌引起的炎症反应,向小鼠注射CAMP疫苗,可以显着增加血清中的抗体浓度,小鼠促炎因子水平下降,痤疮比对照组明显减少!用单克隆抗体中和人皮肤细胞中的CAMP,同样得到了促炎因子水平下降的结果!

J Cos Dermat:广西大学科学家找到了导致青春痘的“罪魁祸首”——血清HCY

近期,发表的一项研究指出,痤疮患者有更高水平的血清同型半胱氨酸(Hcy),研究结果发表于在线《化妆品皮肤病学》杂志上。

Dermira将终止olumacostat glasaretil的研发

Dermira近日表示,在实验性药物不能满足中度至重度痤疮患者的两项III期临床研究的共同主要终点后,可能会停止olumacostat glasaretil的开发。 “我们对结果感到惊讶和非常失望,”首席执行官Tom Wiggans表示。olumacostat glasaretil 是首个 ACC 抑制剂,ACC 催化脂肪酸全合成的第一步反应(限速步骤),所以寻找脂肪代谢失调疾病新药时人们经常会想